Global Cardiac Monitoring Market 2017-2021

  • ID: 4400181
  • Report
  • Region: Global
  • 102 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • Cheetah Medical
  • dms-service
  • GE Healthcare
  • LiDCO
  • Medtronic
  • MORE
About Cardiac Monitoring

Cardiac monitoring refers to the continuous or intermittent observation of heart activity to determine the health of the heart. It helps diagnose cardiac arrhythmias and other heart conditions. Cardiac monitoring devices include ECG devices, cardiac event monitors, ILRs, and COM devices.

ECG devices are non-invasive diagnostic tools that are commonly used to monitor and record the electrical and muscular activity of the heart.

The analysts forecast the global cardiac monitoring market to grow at a CAGR of 8.12% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac monitoring market for 2017-2021. To calculate the market size, the report considers the revenues generated from the sales of cardiac monitoring devices.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Cardiac Monitoring Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
  • Abbott
  • GE Healthcare
  • Hill-Rom
  • Medtronic
  • Philips Healthcare
Other prominent vendors
  • BioTelemetry
  • BIOTRONIK
  • Cheetah Medical
  • Deltex Medical
  • dms-service
  • Edwards Lifesciences
  • LiDCO
  • Manatec Biomedical
  • Midmark
  • NIHON KOHDEN
  • Schiller
  • SORIN GROUP
  • Spacelabs Healthcare
Market drivers
  • Increasing prevalence of CVDs
  • For a full, detailed list, view the full report
Market challenges
  • High cost of cardiac monitoring devices
  • For a full, detailed list, view the full report
Market trends
  • Increasing number of M&A and strategic collaborations
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Cheetah Medical
  • dms-service
  • GE Healthcare
  • LiDCO
  • Medtronic
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Overview
PART 05: Market landscape
  • Overview
  • Market size and forecast
  • Five forces analysis
PART 06: Segmentation by product type
  • Overview
  • ECG devices
  • ILRs
  • Cardiac event monitors
  • COM devices
PART 07: Segmentation by geography
  • Overview
  • Americas
  • EMEA
  • APAC
PART 08: Decision framework

PART 09: Drivers and challenges
  • Market drivers
  • Market challenges
PART 10: Market trends
  • Increasing number of M&A and strategic collaborations
  • Increasing adoption of portable cardiac monitoring devices
PART 11: Vendor landscape
  • Competitive landscape
PART 12: Key vendor analysis
  • Abbott
  • GE Healthcare
  • Hill-Rom
  • Medtronic
  • Philips Healthcare
  • Other prominent vendors
PART 13: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Global cardiac monitoring market: Segmentation
Exhibit 02: Global cardiac monitoring market 2016-2021 ($ millions)
Exhibit 03: Five forces analysis
Exhibit 04: Global cardiac monitoring market: Segmentation by product type 2016 (% share)
Exhibit 05: Global ECG devices market 2016-2021 ($ millions)
Exhibit 06: Global ECG devices market: Segmentation by product type
Exhibit 07: Global ECG devices market: Segmentation by product type (% share)
Exhibit 08: Major resting ECG devices
Exhibit 09: Global resting ECG devices market 2016-2021 ($ millions)
Exhibit 10: Major stress ECG devices
Exhibit 11: Global stress ECG devices market 2016-2021 ($ millions)
Exhibit 12: Major Holter monitoring systems
Exhibit 13: Global Holter monitoring systems market 2016-2021 ($ millions)
Exhibit 14: Major ILRs
Exhibit 15: Global ILRs market 2016-2021 ($ millions)
Exhibit 16: Major cardiac event monitors
Exhibit 17: Global cardiac event monitors market 2016-2021 ($ millions)
Exhibit 18: Major COM devices
Exhibit 19: Global COM devices market 2016-2021 ($ millions)
Exhibit 20: Global cardiac monitoring market: Segmentation by geography 2016 (% share)
Exhibit 21: Cardiac monitoring market in Americas 2016-2021 ($ millions)
Exhibit 22: Cardiac monitoring market in EMEA 2016-2021 ($ millions)
Exhibit 23: Cardiac monitoring market in APAC 2016-2021 ($ millions)
Exhibit 24: Global cardiac monitoring market: Competitive structure analysis 2016
Exhibit 25: Abbott: Key highlights
Exhibit 26: Abbott Laboratories: Strength assessment
Exhibit 27: Abbott Laboratories: Strategy assessment
Exhibit 28: Abbott Laboratories: Opportunity assessment
Exhibit 29: GE Healthcare: Key highlights
Exhibit 30: GE Healthcare: Strength assessment
Exhibit 31: GE Healthcare: Strategy assessment
Exhibit 32: GE Healthcare: Opportunity assessment
Exhibit 33: Hill-Rom: Key highlights
Exhibit 34: Hill-Rom: Strength assessment
Exhibit 35: Hill-Rom: Strategy assessment
Exhibit 36: Hill-Rom: Opportunity assessment
Exhibit 37: Medtronic: Key highlights
Exhibit 38: Medtronic: Strength assessment
Exhibit 39: Medtronic: Strategy assessment
Exhibit 40: Medtronic: Opportunity assessment
Exhibit 41: Philips: Key highlights
Exhibit 42: Philips Healthcare: Strength assessment
Exhibit 43: Philips Healthcare: Strategy assessment
Exhibit 44: Philips Healthcare: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Cheetah Medical
  • dms-service
  • GE Healthcare
  • LiDCO
  • Medtronic
  • MORE
New Report Released: – Global Cardiac Monitoring Market 2017-2021

The author of the report recognizes the following companies as the key players in the global cardiac monitoring market: Abbott, GE Healthcare, Hill-Rom, Medtronic, and Philips Healthcare

Other Prominent Vendors in the market are: BIOTRONIK, Cheetah Medical, Deltex Medical, dms-service, Edwards Lifesciences, LiDCO, Manatec Biomedical, Midmark, NIHON KOHDEN, Schiller, SORIN GROUP, and Spacelabs Healthcare.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is Increasing number of M&A and strategic collaborations. Strategic M&A and collaborations are common in the global cardiac monitoring market. The key vendors acquire other companies to improve their products and increase their revenues. For instance, in January 2017, Abbott announced that it had completed the acquisition of St. Jude Medical. The acquisition provides Abbott with expanded opportunities for future growth. It will also help the company develop a strong and diverse portfolio of devices, diagnostics, nutritionals, and branded generic pharmaceuticals.”

According to the report, one of the major drivers for this market is Increasing prevalence of CVDs. The prevalence of CVDs such as angina, MI, stroke, heart failure, venous thromboembolism (VTE), and heart arrhythmia is increasing. CVDs are estimated to cause approximately 19 million deaths across the world by 2020. According to Eurostat, in 2013, CVDs caused 1.9 million deaths in the EU-28. According to the CDC, in the US, each year, approximately 610,000 people die from heart disease. Every year, in the US, about 735,000 people have a heart attack and about 795,000 people have a stroke.

Further, the report states that one of the major factors hindering the growth of this market is High cost of cardiac monitoring devices. The high cost of cardiac monitoring devices such as ECG devices and ILRs is affecting their adoption. ECG devices that are offered by key vendors such as GE Healthcare, Philips Healthcare, and NIHON KOHDEN cost around $1,000-$3,000. Hence, these devices are bought mostly by Tier-1 and Tier-2 hospitals. Patients without insurance find it difficult to afford ECG tests. For instance, the average cost of a provider-administered ECG test in the US is around $1500-$2000. This includes the cost of the test and the interpretation of the result by a trained cardiologist. Many vendors are developing alternative ECG devices such as ReadMyHeart, which is by DailyCare BioMedical, and AliveCor, which is offered by AliveCor, that use one to three leads, rely solely on integrated digital displays, are handheld, and inexpensive.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • GE Healthcare
  • Hill-Rom
  • Medtronic
  • Philips Healthcare
  • BIOTRONIK
  • Cheetah Medical
  • Deltex Medical
  • dms-service
  • Edwards Lifesciences
  • LiDCO
  • Manatec Biomedical
  • Midmark
  • NIHON KOHDEN
  • Schiller
  • SORIN GROUP
  • Spacelabs Healthcare
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll